Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Novolog (Pharm-Up 1966) Revenue

Novolog (Pharm-Up 1966) had revenue of 451.87M ILS in the quarter ending June 30, 2026, with 2.30% growth. This brings the company's total for the last twelve months to 1.81B, down -10.98% year-over-year. In the year 2025, Novolog (Pharm-Up 1966) had annual revenue of 1.81B, down -10.70%. That makes Novolog (Pharm-Up 1966) the 10,378th largest company in the world by revenue and 86th in Israel.

• Revenue (ttm): 1.81B
• Revenue Growth: -10.98%
• P/S Ratio: 0.25
• Revenue / Employee: 1.98M
• Employees: 916
• Market Cap: 450.59M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Logistics Division 1.56B 86.4%
• Health Services Division 217.88M 12.1%
• The Digital Division 27.35M 1.5%

Fiscal year ended Dec 31, 2025 See the full Novolog (Pharm-Up 1966) breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.81B	-216.22M	-10.70%
Dec 31, 2024	2.02B	378.11M	23.01%
Dec 31, 2023	1.64B	135.54M	8.99%
Dec 31, 2022	1.51B	252.70M	20.13%
Dec 31, 2021	1.26B	121.61M	10.73%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error